mTOR/miR-145-regulated exosomal GOLM1 promotes hepatocellular carcinoma through augmented GSK-3β/MMPs

Xiaochen Gai^a,
Bufu Tang^{b, c, d},
Fangming Liu^a,
Yuting Wu^a,
Fang Wang^a,
Yanling Jing^a,
Fuqiang Huang^a,
Di Jin^e,
Ling Wang^{b
, ,},
Hongbing Zhang^{a, f
, ,}

a.
State Key Laboratory of Medical Molecular Biology, Department of Physiology, Institute of Basic Medical Sciences and School of Basic Medicine, Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100005, China
b.
First Affiliated Hospital, Dalian Medical University, Dalian, 116011, China
c.
Department of Radiology, Lishui Hospital of Zhejiang University, Lishui, 323000, China
d.
Department of Radiology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 323000, China
e.
Institute of Cancer Stem Cell, Dalian Medical University, Dalian, 116044, China
f.
Department of Neurology, Institute of Neural Regeneration and Repair, The First People's Hospital of Yichang, College of Medicine, Three Gorges University, Yichang, 443000, China

More Information

Corresponding author: E-mail address: lingwang2006@hotmail.com (Ling Wang); E-mail address: hbzhang@ibms.pumc.edu.cn (Hongbing Zhang)

摘要

- /
- /
- /
Abstract: Golgi membrane protein 1 (GOLM1/GP73) is a serum marker of hepatocellular carcinoma (HCC). We have previously shown that mTOR promoted tumorigenesis of HCC through stimulating GOLM1 expression. In this study, we demonstrated that the mammalian target of rapamycin (mTOR) was a negative regulator of microRNA-145 (miR-145) expression. miR-145 inhibited GOLM1 expression by targeting a coding sequence of GOLM1 gene. GOLM1 and miR-145 were inversely correlated in human HCC tissues. GOLM1-enriched exosomes activated the glycogen synthase kinase-3β/matrix metalloproteinases (GSK-3β/MMPs) signaling axis of recipient cells and accelerated cell proliferation and migration. In contrast, miR-145 suppressed tumorigenesis and metastasis. We suggest that mTOR/miR-145/GOLM1 signaling pathway should be targeted for HCC treatment.
- GOLM1 /
- mTOR /
- Exosome /
- Hepatocellular carcinoma

HTML全文

参考文献(35)

[1]	Ayuko, H., Bruno, C.S., Shen, T.L., Goncalo, R., Ayako, H., Tesic, M.M., Henrik, M., Shinji, K., Di, G.A., Sophia, C., 2015. Tumour exosome integrins determine organotropic metastasis. Nature 527, 329.
[2]	Barkho, B.Z., Munoz, A.E., Li, X., Li, L., Cunningham, L.A., Zhao, X., 2010. Endogenous matrix metalloproteinase (MMP)-3 and MMP-9 promote the differentiation and migration of adult neural progenitor cells in response to chemokines. Stem Cells 26, 3139-3149.
[3]	Blenis, J., 2017. TOR, the gateway to cellular metabolism, cell growth, and disease. Cell 171, 10.
[4]	Block, T.M., Comunale, M.A., Lowman, M., Steel, L.F., Romano, P.R., Fimmel, C., Tennant, B.C., London, W.T., Evans, A.A., Blumberg, B.S., 2005. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc. Natl. Acad. Sci. U. S. A. 102, 779.
[5]	Chang, Y., Liu, C., Yang, J., Liu, G., Feng, F., Tang, J., Hu, L., Li, L., Jiang, F., Chen, C., 2013. MiR-20a triggers metastasis of gallbladder carcinoma. J. Hepatol. 59, 518-527.
[6]	Chen, X., Wang, Y., Tao, J., Shi, Y., Gai, X., Huang, F., Ma, Q., Zhou, Z., Chen, H., Zhang, H., 2015. mTORC1 upregulates GP73 to promote proliferation and migration of hepatocellular carcinoma cells and growth of xenograft tumors in mice. Gastroenterology 149, 741-752.e714.
[7]	Cota, D., Proulx, K., Smith, K.A., Kozma, S.C., Thomas, G., Woods, S.C., Seeley, R.J., 2006. Hypothalamic mTOR signaling regulates food intake. Science 312, 927-930.
[8]	Devulapally, R., Sekar, N.M., Sekar, T.V., Foygel, K., Massoud, T.F., Willmann, J.K., Paulmurugan, R., 2015. Polymer nanoparticles mediated codelivery of antimiR-10b and antimiR-21 for achieving triple negative breast cancer therapy. Acs. Nano. 9, 2290.
[9]	Gong, Y., Hart, E., Shchurin, A., Hooverplow, J., 2008. Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice. J. Clin. Invest. 118, 3012-3024.
[10]	Holz, M.K., Ballif, B.A., Gygi, S.P., Blenis, J., 2005. mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 123, 569-580.
[11]	Huang, J., Wang, Y., Guo, Y., Sun, S., 2010. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology 52, 60.
[12]	Inoki, K., Zhu, T., Guan, K.L., 2003. TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577-590.
[13]	Jin, D., Tao, J., Li, D., Wang, Y., Li, L., Hu, Z., Zhou, Z., Chang, X., Qu, C., Zhang, H., 2015. Golgi protein 73 activation of MMP-13 promotes hepatocellular carcinoma cell invasion. Oncotarget 6, 33523.
[14]	Kim, E., Gorakshahicks, P., Li, L., Neufeld, T.P., Guan, K.L., 2008. Regulation of TORC1 by Rag GTPases in nutrient response. Nat. Cell Biol. 10, 935.
[15]	Kladney, R.D., Cui, X., Bulla, G.A., Brunt, E.M., Fimmel, C.J., 2002. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease. Hepatology 35, 1431.
[16]	Kristiansen, G., Fritzsche, F.R., Wassermann, K., Jager, C., Tolle, A., Lein, M., Stephan, C., Jung, K., Pilarsky, C., Dietel, M., 2008. GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics. Br. J. Cancer 99, 939-948.
[17]	Laxman, B., Morris, D.S., Yu, J., Siddiqui, J., Cao, J., Mehra, R., Lonigro, R.J., Tsodikov, A., Wei, J.T., Tomlins, S.A., 2008. A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer. Cancer Res. 68, 645.
[18]	Ma, J., Meng, Y., Kwiatkowski, D.J., Chen, X., Peng, H., Sun, Q., Zha, X., Wang, F., Wang, Y., Jing, Y., 2010. Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade. J. Clin. Invest. 120, 103.
[19]	Ma, J., Sun, Q., Mi, R., Zhang, H., 2011. Avian influenza A virus H5N1 causes autophagy-mediated cell death through suppression of mTOR signaling. J. Genet. Genomics 38, 533-537.
[20]	Manfred, D., Marc-Oliver, R., Glen, K., Fritzsche, F.R., Beibei, O., 2010. GOLPH2 expression may serve as diagnostic marker in seminomas. BMC Urology,10,1(2010-02-25) 10, 1-6.
[21]	Mao, Y., Yang, H., Xu, H., Lu, X., Sang, X., Du, S., Zhao, H., Chen, W., Xu, Y., Chi, T., 2010. Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma. Gut 59, 1687-1693.
[22]	Marrero, J.A., Romano, P.R., Nikolaeva, O., Steel, L., Mehta, A., Fimmel, C.J., Comunale, M.A., D'Amelio, A., Lok, A.S., Block, T.M., 2005. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. J. Hepatol. 43, 1007-1012.
[23]	Matei, I., Kim, H.S., Lyden, D., 2017. Unshielding exosomal RNA unleashes tumor growth and metastasis. Cell 170, 223.
[24]	Sabbota, A.L., Kim, H.R.C., Zhe, X., Fridman, R., Bonfil, R.D., Cher, M.L., 2010. Shedding of RANKL by tumor-Associated MT1-MMP activates src-dependent prostate cancer cell migration. Cancer Res. 70, 5558.
[25]	Sancak, Y., Peterson, T.R., Shaul, Y.D., Lindquist, R.A., Thoreen, C.C., Barpeled, L., Sabatini, D.M., 2008. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320, 1496-1501.
[26]	Sieghart, W., Fuereder, T., Schmid, K., Cejka, D., Werzowa, J., Wrba, F., Wang, X., Gruber, D., Rasoul-Rockenschaub, S., Peck-Radosavljevic, M., 2007. Mammalian target of rapamycin pathway activity in hepatocellular carcinomas of patients undergoing liver transplantation. Transplantation 83, 425.
[27]	Sun, Q., Chen, X., Ma, J., Peng, H., Wang, F., Zha, X., Wang, Y., Jing, Y., Yang, H., Chen, R., 2011. Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth. Proc. Natl. Acad. Sci. U. S. A. 108, 4129.
[28]	Trehoux, S., Lahdaoui, F., Delpu, Y., Renaud, F., Leteurtre, E., Torrisani, J., Jonckheere, N., Van, S.I., 2015. Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells. Biochim. Biophys. Acta 1853, 2392.
[29]	Varambally, S., Laxman, B., Mehra, R., Cao, Q., Dhanasekaran, S.M., Tomlins, S.A., Granger, J., Vellaichamy, A., Sreekumar, A., Yu, J., 2008. Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer. Neoplasia 10, 1285.
[30]	Villanueva, A., 2019. Hepatocellular carcinoma. N. Engl. J. Med. 380, 1450-1462.
[31]	Wei, S., Dunn, T.A., Isaacs, W.B., Marzo, A.M.D., Luo, J., 2010. GOLPH2 and MYO6: Putative prostate cancer markers localized to the golgi apparatus. Prostate 68, 1387-1395.
[32]	Ying, W., Riopel, M., Bandyopadhyay, G., Dong, Y., Birmingham, A., Seo, J.B., Ofrecio, J.M., Wollam, J., Hernandezcarretero, A., Fu, W., 2017. Adipose tissue macrophage-derived exosomal miRNAs can modulate in vivo and in vitro insulin sensitivity. Cell 171, 372.
[33]	Zhang, H., Cicchetti, G., Onda, H., Koon, H.B., Asrican, K., Bajraszewski, N., Vazquez, F., Carpenter, C.L., Kwiatkowski, D.J., 2003. Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J. Clin. Invest. 112, 1223.
[34]	Zhang, H., Bajraszewski, N., Wu, E., Wang, H., Moseman, A.P., Dabora, S.L., Griffin, J.D., Kwiatkowski, D.J., 2007. PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR. J. Clin. Invest. 117, 730.
[35]	Zhang, F., Gu, Y., Li, X., Wang, W., He, J., Peng, T., 2010. Up-regulated Golgi phosphoprotein 2 (GOLPH2) expression in lung adenocarcinoma tissue. Clin. Biochem. 43, 983.

施引文献

资源附件(0)

访问统计

点击查看大图

计量

文章访问数: 79
HTML全文浏览量: 22
PDF下载量: 5
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

doi: 10.1016/j.jgg.2019.03.013

计量

mTOR/miR-145-regulated exosomal GOLM1 promotes hepatocellular carcinoma through augmented GSK-3β/MMPs

Corresponding author: E-mail address: lingwang2006@hotmail.com (Ling Wang); E-mail address: hbzhang@ibms.pumc.edu.cn (Hongbing Zhang)

计量

目录

留言板

doi: 10.1016/j.jgg.2019.03.013

计量

出版历程

mTOR/miR-145-regulated exosomal GOLM1 promotes hepatocellular carcinoma through augmented GSK-3β/MMPs

Corresponding author: E-mail address: lingwang2006@hotmail.com (Ling Wang); E-mail address: hbzhang@ibms.pumc.edu.cn (Hongbing Zhang)

计量

出版历程

目录